| 1 | Persistent dysbiosis of duodenal microbiota in patients with controlled pediatric Crohn's disease after resolution of inflammation. (Pierce R, Jan NJ, Kumar P, Middleton J, Petri WA, Marie C) Sci Rep 2024 Jun 03;14(1):12668 |
| 1 | Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts. (Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht AL, Brensinger CM, Wu GD, Bittinger K, DINE-CD, SPARC IBD Investigators) Cell Mol Gastroenterol Hepatol 2024;18(3):101357 2 Citations |
| 1 | Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD. (Alizadeh M, Motwani K, Siaton BC, Abutaleb A, Ravel J, Cross RK, SPARC-IBD Investigators
) Inflamm Bowel Dis 2024 Nov 04;30(11):2027-2036 3 Citations |
| 1 | Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. (Kayal M, Deepak P, Beniwal-Patel P, Raffals L, Dubinsky M, Chang S, Higgins PDR, Jiang Y, Cross RK, Long MD, Herfarth HH, Barnes EL) Am J Gastroenterol 2024 Mar 01;119(3):584-587 |
| 1 | Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization. (Geem D, Hercules D, Pelia RS, Venkateswaran S, Griffiths A, Noe JD, Dotson JL, Snapper S, Rabizadeh S, Rosh JR, Baldassano RN, Markowitz JF, Walters TD, Ananthakrishnan A, Sharma G, Denson LA, Hyams JS, Kugathasan S) Clin Gastroenterol Hepatol 2024 Feb;22(2):368-376.e4 7 Citations |
| 1 | Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. (Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P) Gastroenterology 2023 Oct;165(4):963-975.e5 13 Citations |
| 1 | Exome Sequencing Implicates DGKZ , ESRRA , and GXYLT1 for Modulating Granuloma Formation in Crohn Disease. (Harris RA, Bush AH, Eagar TN, Qian J, Greenwood MP, Opekun AR, Baldassano R, Guthery SL, Noe JD, Otley A, Rosh JR, Kugathasan S, Kellermayer R) J Pediatr Gastroenterol Nutr 2023 Sep 01;77(3):354-357 2 Citations |
| 1 | Perioperative nutrition in the setting of pediatric inflammatory bowel disease. (Wong J, Densmore J, Hilbrands J, Elkadri A, Cabrera J, Noe J, Eickhoff J, Goday PS) Nutr Clin Pract 2024 Feb;39(1):184-192 2 Citations |
| 1 | Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. (Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB,
for the ImproveCareNow Network
) J Pediatr Gastroenterol Nutr 2023 May 01;76(5):566-575 8 Citations |
| 2 | The Diagnostic Dilemma of Acute Granulomatous Hepatitis in a Patient With Crohn's Disease: A Case Report and Review of Literature. (Saad E, Agab M, Ozcekirdek EC, Awadelkarim A, Idris I) J Investig Med High Impact Case Rep 2022;10:23247096211069764 4 Citations |
| 1 | Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. (Colman RJ, Xiong Y, Mizuno T, Hyams JS, Noe JD, Boyle B, D'Haens GR, van Limbergen J, Chun K, Yang J, Rosen MJ, Denson LA, Vinks AA, Minar P) Aliment Pharmacol Ther 2022 Mar;55(5):593-603 27 Citations |
| 1 | Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures as Clinical Trial Endpoints: Experience from a Multicenter Pragmatic Trial in Children with Crohn's Disease. (Miller TL, Schuchard J, Carle AC, Forrest CB, Kappelman MD, COMBINE Study Group) J Pediatr 2022 Mar;242:86-92.e3 8 Citations |
| 1 | Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression. (Mo A, Nagpal S, Gettler K, Haritunians T, Giri M, Haberman Y, Karns R, Prince J, Arafat D, Hsu NY, Chuang LS, Argmann C, Kasarskis A, Suarez-Farinas M, Gotman N, Mengesha E, Venkateswaran S, Rufo PA, Baker SS, Sauer CG, Markowitz J, Pfefferkorn MD, Rosh JR, Boyle BM, Mack DR, Baldassano RN, Shah S, LeLeiko NS, Heyman MB, Griffiths AM, Patel AS, Noe JD, Davis Thomas S, Aronow BJ, Walters TD, McGovern DPB, Hyams JS, Kugathasan S, Cho JH, Denson LA, Gibson G) Am J Hum Genet 2021 Sep 02;108(9):1765-1779 8 Citations |
| 2 | BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease. (Gonzalez MM, Bamidele AO, Svingen PA, Sagstetter MR, Smyrk TC, Gaballa JM, Hamdan FH, Kosinsky RL, Gibbons HR, Sun Z, Ye Z, Nair A, Ramos GP, Braga Neto MB, Wixom AQ, Mathison AJ, Johnsen SA, Urrutia R, Faubion WA Jr) J Clin Invest 2021 Jun 15;131(12) 16 Citations |
| 1 | Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis. (Hanzel J, Almradi A, Istl AC, Yang ML, Fleshner KA, Parker CE, Guizzetti L, Ma C, Singh S, Jairath V) Dig Dis Sci 2022 Feb;67(2):646-660 7 Citations |
| 1 | Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction. (Sinh P, Tabibian JH, Biyani PS, Mehta K, Mansoor E, Loftus EV Jr, Dave M) Dig Dis Sci 2021 Dec;66(12):4169-4177 8 Citations |
| 1 | Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease. (Xiong Y, Mizuno T, Colman R, Hyams J, Noe JD, Boyle B, Tsai YT, Dong M, Jackson K, Punt N, Rosen MJ, Denson LA, Vinks AA, Minar P) Clin Pharmacol Ther 2021 Jun;109(6):1639-1647 45 Citations |
| 1 | Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. (Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P) Clin Gastroenterol Hepatol 2021 Oct;19(10):2207-2209.e3 23 Citations |
| 1 | Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study. (Khoudari G, Mansoor E, Click B, Alkhayyat M, Saleh MA, Sinh P, Katz J, Cooper GS, Regueiro M) Clin Gastroenterol Hepatol 2022 May;20(5):e974-e983 41 Citations |
| 1 | Pediatric patients with orofacial granulomatosis likely to subsequently develop intestinal Crohn's disease: Brief Report. (Chen KL, Diiorio DA, Chiu YE, Sokumbi O) Pediatr Dermatol 2020 Nov;37(6):1162-1164 3 Citations |
| 1 | Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease. (Colman RJ, Tsai YT, Jackson K, Boyle BM, Noe JD, Hyams JS, D'Haens GRAM, van Limbergen J, Rosen MJ, Denson LA, Minar P) Inflamm Bowel Dis 2021 Jun 15;27(7):1045-1051 19 Citations |
| 1 | Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center. (Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, Foong J, Turinsky AL, Bronte-Tinkew D, Zhang S, Hu J, Tian D, Li D, Horowitz J, Siddiqui I, Upton J, Roifman CM, Church PC, Wall DA, Ramani AK, Kotlarz D, Klein C, Uhlig H, Snapper SB, Gonzaga-Jauregui C, Paterson AD, McGovern DPB, Brudno M, Walters TD, Griffiths AM, Muise AM) Gastroenterology 2020 Jun;158(8):2208-2220 85 Citations |
| 1 | Alterations in brain white matter microstructural properties in patients with Crohn's disease in remission. (Hou J, Dodd K, Nair VA, Rajan S, Beniwal-Patel P, Saha S, Prabhakaran V) Sci Rep 2020 Feb 07;10(1):2145 17 Citations |
| 1 | Severe terminal ileitis induced by single-agent nivolumab administered every four weeks. (Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J) J Oncol Pharm Pract 2020 Sep;26(6):1516-1519 3 Citations |
| 1 | Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure. (Gupta N, Liu C, King E, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Colletti R, ImproveCareNow Network) Inflamm Bowel Dis 2020 Nov 19;26(12):1880-1889 20 Citations |
| 1 | Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. (Burmester GR, Gordon KB, Rosenbaum JT, Arikan D, Lau WL, Li P, Faccin F, Panaccione R) Adv Ther 2020 Jan;37(1):364-380 57 Citations |
| 1 | Letter: pre-operative anti-TNF therapy in Crohn's disease is not associated with increased complications following elective surgery. (Istl A, Yang ML, Fleshner KA, Parker CE, Guizzetti L, Singh S, Jairath V) Aliment Pharmacol Ther 2019 Aug;50(4):467-468 1 Citation |
| 1 | Dietary Management of Pediatric Inflammatory Bowel Disease. (Kaenkumchorn T, Kesavan A) J Med Food 2019 Nov;22(11):1092-1099 16 Citations |
| 1 | A Verbal Fluency Task-Based Brain Activation fMRI Study in Patients with Crohn's Disease in Remission. (Nair VA, Dodd K, Rajan S, Santhanubosu A, Beniwal-Patel P, Saha S, Prabhakaran V) J Neuroimaging 2019 Sep;29(5):630-639 13 Citations |
| 1 | Alterations in resting-state functional connectivity in patients with Crohn's disease in remission. (Hou J, Mohanty R, Nair VA, Dodd K, Beniwal-Patel P, Saha S, Prabhakaran V) Sci Rep 2019 May 15;9(1):7412 21 Citations |
| 1 | Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease. (Wu J, Lubman DM, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC, Griffiths AM, Baldassano RN, Noe JD, Rabizadeh S, Gulati AS, Rosh JR, Crandall WV, Higgins PDR, Stidham RW) Am J Gastroenterol 2019 May;114(5):777-785 40 Citations |
| 1 | Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. (Yarur AJ, Bruss A, Naik S, Beniwal-Patel P, Fox C, Jain A, Berens B, Patel A, Ungaro R, Bahur B, Dubinsky M, Stein DJ) Dig Dis Sci 2019 Jun;64(6):1651-1659 36 Citations |
| 1 | Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. (Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, Gutierrez AM, Beniwal-Patel P, Palam S, Syal G, Herfarth HH, Christophi G, Raffals L, Barnes EL, Deepak P) Inflamm Bowel Dis 2019 Aug 20;25(9):1569-1576 54 Citations |
| 1 | Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. (Somineni HK, Venkateswaran S, Kilaru V, Marigorta UM, Mo A, Okou DT, Kellermayer R, Mondal K, Cobb D, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Dubinsky MC, Cho J, Hyams JS, Denson LA, Gibson G, Cutler DJ, Conneely KN, Smith AK, Kugathasan S) Gastroenterology 2019 Jun;156(8):2254-2265.e3 97 Citations |
| 2 | Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression. (Perera LP, Radigan M, Guilday C, Banerjee I, Eastwood D, Babygirija R, Massey BT) Dig Dis Sci 2019 Jul;64(7):1923-1928 36 Citations |
| 1 | Prioritizing Crohn's disease genes by integrating association signals with gene expression implicates monocyte subsets. (Gettler K, Giri M, Kenigsberg E, Martin J, Chuang LS, Hsu NY, Denson LA, Hyams JS, Griffiths A, Noe JD, Crandall WV, Mack DR, Kellermayer R, Abraham C, Hoffman G, Kugathasan S, Cho JH) Genes Immun 2019 Sep;20(7):577-588 12 Citations |
| 1 | Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study. (Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, Kellermayer R, Leleiko NS, Mack DR, Markowitz JF, Moulton DE, Noe JD, Otley AR, Patel AS, Pfefferkorn M, Rabizadeh S, Rosh JR, Snapper S, Walters TD, Ziring D, Mondal K, Kappelman MD, Hyams JS, Kugathasan S) Inflamm Bowel Dis 2019 Jun 18;25(7):1208-1217 19 Citations |
| 1 | Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. (Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Kirschner BS, Keljo DJ, Guthery SL, Cohen SA, Snapper S, Evans J, Dubinsky M, Aronow B, Hyams JS, Kugathasan S, Huttenhower C, Xavier RJ, Denson LA) Mucosal Immunol 2019 Mar;12(2):491-502 23 Citations |
| 1 | Obstructive nephropathy: simple yet complicated! (Koratala A, Morales Lappot J) Intern Emerg Med 2019 Mar;14(2):315-317 2 Citations |
| 1 | Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort. (Weaver KN, Gregory M, Syal G, Hoversten P, Hicks SB, Patel D, Christophi G, Beniwal-Patel P, Isaacs KL, Raffals L, Deepak P, Herfarth HH, Barnes EL) Inflamm Bowel Dis 2019 Mar 14;25(4):767-774 68 Citations |
| 1 | The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children. (Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN) Am J Gastroenterol 2018 Oct;113(10):1524-1529 34 Citations |
| 1 | Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease. (Denson LA, Jurickova I, Karns R, Shaw KA, Cutler DJ, Okou D, Valencia CA, Dodd A, Mondal K, Aronow BJ, Haberman Y, Linn A, Price A, Bezold R, Lake K, Jackson K, Walters TD, Griffiths A, Baldassano RN, Noe JD, Hyams JS, Crandall WV, Kirschner BS, Heyman MB, Snapper S, Guthery SL, Dubinsky MC, Leleiko NS, Otley AR, Xavier RJ, Stevens C, Daly MJ, Zwick ME, Kugathasan S) Inflamm Bowel Dis 2019 Feb 21;25(3):547-560 9 Citations |
| 1 | Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization. (Pezhouh MK, Miller JA, Sharma R, Borzik D, Eze O, Waters K, Westerhoff MA, Parian AM, Lazarev MG, Voltaggio L) Hum Pathol 2018 Dec;82:187-192 19 Citations |
| 1 | Ascites in a Young Woman With Inflammatory Bowel Disease. (Vicetti Miguel CP, Ardura MI) J Pediatric Infect Dis Soc 2018 Aug 17;7(3):264-266 |
| 5 | A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis. (Jeschke JC, Mayne CG, Ziegelbauer J, DeCiantis CL, Singh S, Kumar SN, Suchi M, Iwakura Y, Drobyski WR, Salzman NH, Williams CB) Mucosal Immunol 2018 Jul;11(4):1127-1137 3 Citations |
| 3 | Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease. (Perera LP, Bhandari S, Liu R, Guilday C, Zadvornova Y, Saeian K, Eastwood D) Dig Dis Sci 2018 Jul;63(7):1787-1793 5 Citations |
| 1 | A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. (Chang YL, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, Humphries R, Stappenbeck T, Simpson KW, Sartor RB, Wu G, Lewis J, Bushman F, McGovern DPB, Salzman N, Borneman J, Xavier R, Huttenhower C, Braun J) Mucosal Immunol 2019 Mar;12(2):457-467 44 Citations |
| 1 | Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. (Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD) Dig Dis Sci 2018 Jun;63(6):1572-1582 35 Citations |
| 1 | Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease. (Denson LA, Jurickova I, Karns R, Shaw KA, Cutler DJ, Okou DT, Dodd A, Quinn K, Mondal K, Aronow BJ, Haberman Y, Linn A, Price A, Bezold R, Lake K, Jackson K, Walters TD, Griffiths A, Baldassano RN, Noe JD, Hyams JS, Crandall WV, Kirschner BS, Heyman MB, Snapper S, Guthery SL, Dubinsky MC, Leleiko NS, Otley AR, Xavier RJ, Stevens C, Daly MJ, Zwick ME, Kugathasan S) Gastroenterology 2018 Jun;154(8):2097-2110 66 Citations |
| 1 | Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease. (Haberman Y, BenShoshan M, Di Segni A, Dexheimer PJ, Braun T, Weiss B, Walters TD, Baldassano RN, Noe JD, Markowitz J, Rosh J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Kellermayer R, Patel A, Otley A, Steiner SJ, Gulati AS, Guthery SL, LeLeiko N, Moulton D, Kirschner BS, Snapper S, Avivi C, Barshack I, Oliva-Hemker M, Cohen SA, Keljo DJ, Ziring D, Anikster Y, Aronow B, Hyams JS, Kugathasan S, Denson LA) Inflamm Bowel Dis 2018 Jan 18;24(2):346-360 55 Citations |
| 1 | Outcomes after fecal diversion for colonic and perianal Crohn disease in children. (Dharmaraj R, Nugent M, Simpson P, Arca M, Gurram B, Werlin S) J Pediatr Surg 2018 Mar;53(3):472-476 12 Citations |
| 4 | Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection. (Bhandari S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, Saeian K, Stein D) Inflamm Bowel Dis 2017 Oct;23(10):1847-1852 19 Citations |
| 1 | Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease. (Marigorta UM, Denson LA, Hyams JS, Mondal K, Prince J, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Kellermayer R, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Kim MO, Dubinsky MC, Cho J, Aronow BJ, Kugathasan S, Gibson G) Nat Genet 2017 Oct;49(10):1517-1521 122 Citations |
| 1 | Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. (Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC) Lancet 2017 Apr 29;389(10080):1710-1718 478 Citations |
| 1 | Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. (Yarur AJ, Kanagala V, Stein DJ, Czul F, Quintero MA, Agrawal D, Patel A, Best K, Fox C, Idstein K, Abreu MT) Aliment Pharmacol Ther 2017 Apr;45(7):933-940 271 Citations |
| 1 | Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. (Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe JD, Griffiths AM, Rosh JR, Crandall WV, Heyman MB, Mack DR, Kappelman MD, Markowitz J, Moulton DE, Leleiko NS, Walters TD, Kugathasan S, Wilson KT, Hogan SP, Denson LA) Gastroenterology 2017 May;152(6):1345-1357.e7 60 Citations |
| 2 | The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD). (Sarmento OF, Svingen PA, Xiong Y, Sun Z, Bamidele AO, Mathison AJ, Smyrk TC, Nair AA, Gonzalez MM, Sagstetter MR, Baheti S, McGovern DP, Friton JJ, Papadakis KA, Gautam G, Xavier RJ, Urrutia RA, Faubion WA) J Biol Chem 2017 Jan 13;292(2):706-722 56 Citations |
| 3 | Paneth cell defects in Crohn's disease patients promote dysbiosis. (Liu TC, Gurram B, Baldridge MT, Head R, Lam V, Luo C, Cao Y, Simpson P, Hayward M, Holtz ML, Bousounis P, Noe J, Lerner D, Cabrera J, Biank V, Stephens M, Huttenhower C, McGovern DP, Xavier RJ, Stappenbeck TS, Salzman NH) JCI Insight 2016 Jun 02;1(8):e86907 89 Citations |
| 1 | The operative management of children with complex perianal Crohn's disease. (Seemann NM, King SK, Elkadri A, Walters T, Fish J, Langer JC) J Pediatr Surg 2016 Dec;51(12):1993-1997 11 Citations |
| 1 | Predictors of Pouchitis After Ileal Pouch-Anal Anastomosis in Children. (Dharmaraj R, Dasgupta M, Simpson P, Noe J) J Pediatr Gastroenterol Nutr 2016 Dec;63(6):e210-e211 9 Citations |
| 1 | Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease. (Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, Stintzi A, Mack D) Inflamm Bowel Dis 2016 Jul;22(7):1533-9 46 Citations |
| 1 | Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease. (Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, Düker G, Bettels R, Rohrbach M, Kugathasan S, Chapel H, Keshav S, Elkadri A, Platt N, Muise AM, Koletzko S, Xavier RJ, Marquardt T, Powrie F, Wraith JE, Gyrd-Hansen M, Platt FM, Uhlig HH) Gut 2017 Jun;66(6):1060-1073 123 Citations |
| 1 | Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease. (Li Q, Lee CH, Peters LA, Mastropaolo LA, Thoeni C, Elkadri A, Schwerd T, Zhu J, Zhang B, Zhao Y, Hao K, Dinarzo A, Hoffman G, Kidd BA, Murchie R, Al Adham Z, Guo C, Kotlarz D, Cutz E, Walters TD, Shouval DS, Curran M, Dobrin R, Brodmerkel C, Snapper SB, Klein C, Brumell JH, Hu M, Nanan R, Snanter-Nanan B, Wong M, Le Deist F, Haddad E, Roifman CM, Deslandres C, Griffiths AM, Gaskin KJ, Uhlig HH, Schadt EE, Muise AM) Gastroenterology 2016 May;150(5):1196-1207 90 Citations |
| 2 | Plasma-induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive paediatric inflammatory bowel disease. (Gurram B, Salzman NH, Kaldunski ML, Jia S, Li BU, Stephens M, Sood MR, Hessner MJ) Clin Exp Immunol 2016 Apr;184(1):36-49 11 Citations |
| 1 | Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials. (Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA) Clin Gastroenterol Hepatol 2015 Dec;13(13):2233-40.e1-2; quiz e177-8 95 Citations |
| 2 | Fox Den Disease: An Interesting Case Following Delayed Diagnosis. (Stehr RC, Kim N, LoGiudice JA, Ludwig K) Wounds 2015 Jun;27(6):170-3 |
| 1 | Adherence to Infliximab Treatment in a Pediatric Inflammatory Bowel Disease Cohort. (Vitale DS, Greenley RN, Lerner DG, Mavis AM, Werlin SL) J Pediatr Gastroenterol Nutr 2015 Oct;61(4):408-10 7 Citations |
| 1 | Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. (Kuenstner JT, Chamberlin W, Naser SA, Collins MT, Dow CT, Aitken JM, Weg S, Telega G, John K, Haas D, Eckstein TM, Kali M, Welch C, Petrie T) World J Gastroenterol 2015 Apr 07;21(13):4048-62 27 Citations |
| 1 | The role of surgery for children with perianal Crohn's disease. (Seemann NM, Elkadri A, Walters TD, Langer JC) J Pediatr Surg 2015 Jan;50(1):140-3 21 Citations |
| 1 | The role of integrin antagonists in the treatment of inflammatory bowel disease. (Beniwal-Patel P, Saha S) Expert Opin Biol Ther 2014 Dec;14(12):1815-23 5 Citations |
| 1 | The diagnostic approach to monogenic very early onset inflammatory bowel disease. (Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D, Klein C, Snapper SB, Muise AM, COLORS in IBD Study Group and NEOPICS) Gastroenterology 2014 Nov;147(5):990-1007.e3 536 Citations |
| 1 | Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. (Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, Kugathasan S, Walters TD, Aronow B, Xavier RJ, Gevers D, Denson LA) J Clin Invest 2014 Aug;124(8):3617-33 395 Citations |
| 1 | Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease. (Goyal A, Hyams JS, Lerer T, Leleiko NS, Otley AR, Griffiths AM, Rosh JR, Cabrera JM, Oliva-Hemker MM, Mack DR, Rick JN, Pfefferkorn MD, Carvalho R, Grossman AB, Hitch MC, Sudel B, Kappelman MD, Saeed SA, Faubion WA, Schaefer ME, Markowitz JF, Keljo DJ, Pediatric Inflammatory Bowel Disease Collaborative Research Group) J Pediatr Gastroenterol Nutr 2014 Sep;59(3):321-3 19 Citations |
| 2 | Chemokines in colitis: microRNA control. (Roy I, Veldkamp CT, Volkman BF, Dwinell MB) Gut 2014 Aug;63(8):1202-4 5 Citations |
| 1 | Serum antibodies associated with complex inflammatory bowel disease. (Elkadri AA, Stempak JM, Walters TD, Lal S, Griffiths AM, Steinhart AH, Silverberg MS) Inflamm Bowel Dis 2013 Jun;19(7):1499-505 30 Citations |
| 1 | Peripheral neuropathy incidence in inflammatory bowel disease: a population-based study. (Figueroa JJ, Loftus EV Jr, Harmsen WS, Dyck PJ, Klein CJ) Neurology 2013 Apr 30;80(18):1693-7 36 Citations |
| 1 | Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. (Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, Brown C, Tung J, Khan K, Faubion W Jr, Park R, Heikenen J, Yaffee M, Rivera-Bennett MT, Wiedkamp M, Stephens M, Noel R, Nugent M, Nebel J, Simpson P, Kappelman MD, Kugathasan S) Inflamm Bowel Dis 2013 May;19(6):1218-23 92 Citations |
| 1 | Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease. (Ananthakrishnan AN, McGinley EL) Aliment Pharmacol Ther 2013 May;37(9):895-904 32 Citations |
| 1 | Treatment of intra-abdominal abscesses in Crohn's disease: a nationwide analysis of patterns and outcomes of care. (Ananthakrishnan AN, McGinley EL) Dig Dis Sci 2013 Jul;58(7):2013-8 25 Citations |
| 1 | PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. (Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I, Rugge M) Virchows Arch 2013 Jan;462(1):57-63 57 Citations |
| 1 | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. (Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B) J Crohns Colitis 2013 Sep;7(8):e279-85 113 Citations |
| 2 | Red flags in children with chronic abdominal pain and Crohn's disease-a single center experience. (El-Chammas K, Majeskie A, Simpson P, Sood M, Miranda A) J Pediatr 2013 Apr;162(4):783-7 34 Citations |
| 1 | Extensive lichen nitidus as a clue to underlying Crohn's disease. (Wanat KA, Elenitsas R, Chachkin S, Lubinski S, Rosenbach M) J Am Acad Dermatol 2012 Nov;67(5):e218-20 7 Citations |
| 1 | Optic perineuritis as the presenting feature of Crohn disease. (McClelland C, Zaveri M, Walsh R, Fleisher J, Galetta S) J Neuroophthalmol 2012 Dec;32(4):345-7 29 Citations |
| 1 | Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. (Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP) Ann Rheum Dis 2013 Apr;72(4):517-24 488 Citations |
| 1 | A vicious cycle. (Acharya KB, Young DR, Wells MA, Quick CM, Lamps L, Bariola JR) Am J Med 2012 Apr;125(4):350-2 1 Citation |
| 1 | Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. (Ananthakrishnan AN, McGinley EL) J Crohns Colitis 2013 Mar;7(2):107-12 160 Citations |
| 1 | Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric Crohn disease. (Steiner SJ, Noe JD, Denne SC) Pediatr Res 2011 Nov;70(5):484-8 26 Citations |
| 3 | Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. (Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M) J Pediatr 2011 Nov;159(5):808-12 65 Citations |
| 1 | Low-dose MDCT and CT enterography of patients with Crohn disease: feasibility of adaptive statistical iterative reconstruction. (Kambadakone AR, Chaudhary NA, Desai GS, Nguyen DD, Kulkarni NM, Sahani DV) AJR Am J Roentgenol 2011 Jun;196(6):W743-52 99 Citations |
| 1 | The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease. (Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D) Am J Physiol Gastrointest Liver Physiol 2011 May;300(5):G823-32 40 Citations |
| 2 | A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. (Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K) J Gastrointest Surg 2011 Feb;15(2):267-76 61 Citations |
| 1 | The status of diagnostic markers for inflammatory bowel disease. (Beniwal P, Harrell L) Curr Gastroenterol Rep 2010 Dec;12(6):479-84 16 Citations |
| 2 | Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. (Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG) Inflamm Bowel Dis 2011 Apr;17(4):976-83 134 Citations |
| 2 | Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. (Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K) Inflamm Bowel Dis 2011 May;17(5):1138-45 139 Citations |
| 1 | Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. (Biswas A, Liu YJ, Hao L, Mizoguchi A, Salzman NH, Bevins CL, Kobayashi KS) Proc Natl Acad Sci U S A 2010 Aug 17;107(33):14739-44 145 Citations |
| 1 | Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. (Jensen MK, Tipnis NA, Bajorunaite R, Sheth MK, Sato TT, Noel RJ) Gastrointest Endosc 2010 Jul;72(1):95-102 48 Citations |
| 2 | A novel risk score to stratify severity of Crohn's disease hospitalizations. (Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K) Am J Gastroenterol 2010 Aug;105(8):1799-807 58 Citations |
| 1 | Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease. (Ippoliti A, Devlin S, Mei L, Yang H, Papadakis KA, Vasiliauskas EA, McGovern DP, Abreu MT, Melmed G, Shaye O, Enayati P, Chen G, Choi J, Taylor K, Landers CJ, Rotter JI, Targan SR) Inflamm Bowel Dis 2010 Aug;16(8):1279-85 27 Citations |
| 2 | Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). (Rafiee P, Stein DJ, Nelson VM, Otterson MF, Shaker R, Binion DG) Am J Physiol Gastrointest Liver Physiol 2010 Feb;298(2):G167-76 34 Citations |
| 1 | Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. (Stein DJ, Ananthakrishnan AN, Issa M, Williams JB, Beaulieu DB, Zadvornova Y, Ward A, Johnson K, Knox JF, Skaros S, Binion DG) Inflamm Bowel Dis 2010 Jul;16(7):1173-9 20 Citations |
| 1 | Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. (Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T, McGovern DP, Erlich HA, Rotter JI, Trachtenberg EA) Immunogenetics 2009 Oct;61(10):663-71 54 Citations |
| 1 | Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease. (Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall W, Carvalho RS, Mack DR, Hyams JS) Am J Gastroenterol 2009 Dec;104(12):3042-9 116 Citations |
| 1 | Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? (Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K, Naik A, Perera L, Issa M, Binion DG, Saeian K) Inflamm Bowel Dis 2010 Mar;16(3):494-500 29 Citations |
| 1 | IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. (Michelsen KS, Thomas LS, Taylor KD, Yu QT, Mei L, Landers CJ, Derkowski C, McGovern DP, Rotter JI, Targan SR) PLoS One 2009;4(3):e4719 82 Citations |
| 1 | Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. (McGovern DP, Rotter JI, Mei L, Haritunians T, Landers C, Derkowski C, Dutridge D, Dubinsky M, Ippoliti A, Vasiliauskas E, Mengesha E, King L, Pressman S, Targan SR, Taylor KD) Inflamm Bowel Dis 2009 Jun;15(6):883-9 65 Citations |
| 1 | Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. (Burmester GR, Mease P, Dijkmans BA, Gordon K, Lovell D, Panaccione R, Perez J, Pangan AL) Ann Rheum Dis 2009 Dec;68(12):1863-9 181 Citations |
| 1 | Spinal abscess presenting as the initial symptom of Crohn's disease. (de la Fuente SG, Safford SD, Cantu E, Ludwig KA) Int J Colorectal Dis 2009 May;24(5):601-2 1 Citation |
| 1 | Steroid induced atrial fibrillation. (Iqbal FM, Beeharilal PS, Sadat K, Mohajer R, Lewis BE) Compr Ther 2008;34(2):111-4 9 Citations |
| 1 | Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation. (Takedatsu H, Taylor KD, Mei L, McGovern DP, Landers CJ, Gonsky R, Cong Y, Vasiliauskas EA, Ippoliti A, Elson CO, Rotter JI, Targan SR) Gut 2009 Jan;58(1):60-7 22 Citations |
| 1 | Palmar-plantar erythrodysesthesia caused by mercaptopurine and mesalamine. (Wanat KA, Bandow GD, Klekotka PA) Arch Dermatol 2008 Aug;144(8):1079-81 1 Citation |
| 1 | Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. (Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG) Inflamm Bowel Dis 2009 Jan;15(1):25-8 93 Citations |
| 1 | Short-term response to adalimumab in childhood inflammatory bowel disease. (Noe JD, Pfefferkorn M) Inflamm Bowel Dis 2008 Dec;14(12):1683-7 37 Citations |
| 1 | IL23R haplotypes provide a large population attributable risk for Crohn's disease. (Taylor KD, Targan SR, Mei L, Ippoliti AF, McGovern D, Mengesha E, King L, Rotter JI) Inflamm Bowel Dis 2008 Sep;14(9):1185-91 38 Citations |
| 1 | Active crohn disease and hypercalcemia treated with infliximab: case report and literature review. (Ioachimescu AG, Bauer TW, Licata A) Endocr Pract 2008;14(1):87-92 12 Citations |
| 1 | Permanent work disability in Crohn's disease. (Ananthakrishnan AN, Weber LR, Knox JF, Skaros S, Emmons J, Lundeen S, Issa M, Otterson MF, Binion DG) Am J Gastroenterol 2008 Jan;103(1):154-61 88 Citations |
| 1 | Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty. (Binion DG, Theriot KR, Shidham S, Lundeen S, Hatoum O, Lim HJ, Otterson MF) J Gastrointest Surg 2007 Dec;11(12):1692-8; dicussion 1698 16 Citations |
| 1 | Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. (Levine A, Kugathasan S, Annese V, Biank V, Leshinsky-Silver E, Davidovich O, Kimmel G, Shamir R, Palmieri O, Karban A, Broeckel U, Cucchiara S) Inflamm Bowel Dis 2007 Dec;13(12):1509-15 54 Citations |
| 2 | Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. (Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG) J Clin Gastroenterol 2007 Aug;41(7):682-8 54 Citations |
| 1 | TNFSF15 is an ethnic-specific IBD gene. (Picornell Y, Mei L, Taylor K, Yang H, Targan SR, Rotter JI) Inflamm Bowel Dis 2007 Nov;13(11):1333-8 82 Citations |
| 1 | Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). (Dassopoulos T, Nguyen GC, Bitton A, Bromfield GP, Schumm LP, Wu Y, Elkadri A, Regueiro M, Siemanowski B, Torres EA, Gregory FJ, Kane SV, Harrell LE, Franchimont D, Achkar JP, Griffiths A, Brant SR, Rioux JD, Taylor KD, Duerr RH, Silverberg MS, Cho JH, Steinhart AH) Inflamm Bowel Dis 2007 Aug;13(8):975-83 40 Citations |
| 2 | Impact of Clostridium difficile on inflammatory bowel disease. (Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG) Clin Gastroenterol Hepatol 2007 Mar;5(3):345-51 486 Citations |
| 1 | Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. (Horowitz S, Binion DG, Nelson VM, Kanaa Y, Javadi P, Lazarova Z, Andrekopoulos C, Kalyanaraman B, Otterson MF, Rafiee P) Am J Physiol Gastrointest Liver Physiol 2007 May;292(5):G1323-36 109 Citations |
| 2 | DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. (Biank V, Friedrichs F, Babusukumar U, Wang T, Stoll M, Broeckel U, Kugathasan S) Am J Gastroenterol 2007 Feb;102(2):391-8 41 Citations |
| 1 | Association between the C3435T polymorphism of the MDR1 gene and Crohn's disease. (Lal S, Stempak JM, Law C, Elkadri AA, Steinhart AH, Silverberg MS) Inflamm Bowel Dis 2006 Oct;12(10):1006-7 6 Citations |
| 2 | Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. (Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S) Am J Gastroenterol 2006 Jun;101(6):1354-61 45 Citations |
| 1 | Crohn's disease presenting as necrotizing fasciitis: a case report. (Kiely JM, Brasel KJ, Graewin SJ, Nowak DM, Christians KK, Nirula R) Am Surg 2005 Oct;71(10):870-1 5 Citations |
| 1 | Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. (Friedrichs F, Brescianini S, Annese V, Latiano A, Berger K, Kugathasan S, Broeckel U, Nikolaus S, Daly MJ, Schreiber S, Rioux JD, Stoll M) Hum Genet 2006 Apr;119(3):305-11 59 Citations |
| 1 | Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. (Binion DG, Kugathasan S, Dwinell MB) Am J Gastroenterol 2006 Jan;101(1):107-9 2 Citations |
| 1 | Reduced Paneth cell alpha-defensins in ileal Crohn's disease. (Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H Jr, Fellermann K, Ganz T, Stange EF, Bevins CL) Proc Natl Acad Sci U S A 2005 Dec 13;102(50):18129-34 853 Citations |
| 2 | Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. (Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Broeckel U, Tolia V) Inflamm Bowel Dis 2005 Jul;11(7):631-8 71 Citations |
| 1 | Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. (Bajaj JS, Saeian K, Varma RR, Franco J, Knox JF, Podoll J, Emmons J, Levy M, Binion DG) Am J Gastroenterol 2005 May;100(5):1121-5 59 Citations |
| 1 | CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. (Kugathasan S, Collins N, Maresso K, Hoffmann RG, Stephens M, Werlin SL, Rudolph C, Broeckel U) Clin Gastroenterol Hepatol 2004 Nov;2(11):1003-9 86 Citations |
| 2 | Radiographic underestimation of small bowel stricturing Crohn's disease: a comparison with surgical findings. (Otterson MF, Lundeen SJ, Spinelli KS, Sudakoff GS, Telford GL, Hatoum OA, Saeian K, Yun H, Binion DG) Surgery 2004 Oct;136(4):854-60 45 Citations |
| 1 | Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. (Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Weisdorf-Schindele S, San Pablo W Jr, Perrault J, Park R, Yaffe M, Brown C, Rivera-Bennett MT, Halabi I, Martinez A, Blank E, Werlin SL, Rudolph CD, Binion DG, Wisconsin Pediatric Inflammatory Bowel Disease Alliance) J Pediatr 2003 Oct;143(4):525-31 533 Citations |
| 1 | Dermatologic manifestations of Crohn disease in children: response to infliximab. (Kugathasan S, Miranda A, Nocton J, Drolet BA, Raasch C, Binion DG) J Pediatr Gastroenterol Nutr 2003 Aug;37(2):150-4 91 Citations |
| 2 | Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. (Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG) J Clin Gastroenterol 2003 Aug;37(2):125-8 39 Citations |
| 1 | Pancreatitis as a presenting manifestation of pediatric Crohn's disease: a report of three cases. (Kugathasan S, Halabi I, Telega G, Werlin SL) J Pediatr Gastroenterol Nutr 2002 Jul;35(1):96-8 13 Citations |
| 1 | Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. (Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, Emmons J, Martinez A, Kelly KJ, Binion DG) Am J Gastroenterol 2002 Jun;97(6):1408-14 124 Citations |
| 1 | Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin. (Prajapati DN, Newcomer JR, Emmons J, Abu-Hajir M, Binion DG) Inflamm Bowel Dis 2002 May;8(3):192-5 25 Citations |
| 1 | Terminal ileum resection is associated with higher plasma homocysteine levels in Crohn's disease. (Vasilopoulos S, Saiean K, Emmons J, Berger WL, Abu-Hajir M, Seetharam B, Binion DG) J Clin Gastroenterol 2001 Aug;33(2):132-6 31 Citations |
| 1 | Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease. (Kader HA, Wenner WJ Jr, Telega GW, Maller ES, Baldassano RN) J Clin Gastroenterol 2000 Jun;30(4):409-13 61 Citations |
| 1 | Increased colonic ornithine decarboxylase activity in inflammatory bowel disease in children. (Pillai RB, Tolia V, Rabah R, Simpson PM, Vijesurier R, Lin CH) Dig Dis Sci 1999 Aug;44(8):1565-70 21 Citations |
| 1 | The cutaneous manifestations of gastrointestinal disease. (Katz SK, Gordon KB, Roenigk HH) Prim Care 1996 Sep;23(3):455-76 12 Citations |
| 1 | Preliminary experience with laparoscopic intestinal surgery for Crohn's disease. (Ludwig KA, Milsom JW, Church JM, Fazio VW) Am J Surg 1996 Jan;171(1):52-5; discussion 55-6 126 Citations |
| 1 | Crohn's disease uveitis. Parasitization of vitreous leukocytes by mollicute-like organisms. (Johnson LA, Wirostko E, Wirostko WJ) Am J Clin Pathol 1989 Mar;91(3):259-64 5 Citations |
| 1 | Familial Crohn's disease, including spouse. (Dua KS, Mowat NA) Scott Med J 1988 Dec;33(6):372-3 3 Citations |
| 1 | Association and linkage studies of immunoglobulin heavy chain allotypes in inflammatory bowel disease. (Gudjonsson H, Schanfield MS, Albertini RJ, McAuliffe TL, Beeken WL, Krawitt EL) Tissue Antigens 1988 May;31(5):243-9 6 Citations |
| 1 | Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. (Harper PC, McAuliffe TL, Beeken WL) Arch Intern Med 1986 Apr;146(4):753-5 86 Citations |
